相关实验视频
Updated: Sep 11, 2025

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
MTHFD2通过Notch信号激活驱动视网膜母细胞瘤的进展:针对儿童眼癌向治疗的含义
Chunyue Yao1, Tingting Chen2, Yijia Chen2
1Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China; Medical Department of Graduate School, Nanchang University, Nanchang, Jiangxi, PR China; Jiangxi Provincial Key Laboratory of Tumor Metastasis and Precision Therapy, Center Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.
甲基基酸脱酶2 (MTHFD2) 在视网膜母细胞瘤 (RB) 中过度表达,促进瘤生长和存活. 抑制MTHFD2可能为这种儿童眼癌提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 视网母细胞瘤 (RB) 是最常见的儿童眼内癌,对于复发或耐药病例的治疗方法有限.
- 单碳代谢中的线粒体酶MTHFD2在许多癌症中过度表达,并与预后不佳有关.
- 在RB进展中MTHFD2的作用以前没有被研究过.
研究的目的:
- 研究MTHFD2在视网膜母细胞瘤进展中的作用和机制.
- 确定MTHFD2是否可以成为RB的潜在治疗点.
主要方法:
- 在RB组织和细胞系中分析MTHFD2表达.
- 使用RB细胞系进行体外研究,以评估MTHFD2过度表达和敲击对细胞活力,细胞亡和殖民地形成的影响.
- RNA测序和KEGG通路分析以确定分子机制.
- 使用瘤异种移植的体内研究来评估MTHFD2下调对瘤生长的影响.
主要成果:
- 在RB组织和细胞系中,MTHFD2被显著上调.
- 过度表达MTHFD2增强了RB细胞活力和殖民地形成,同时抑制了亡.
- MTHFD2敲击抑制了RB细胞的生长,并诱导了亡.
- 标记信号通路的MTHFD2激活被确定为一个关键机制.
- 在体内,MTHFD2下调抑制了瘤生长,并减少了Ki67的表达.
结论:
- MTHFD2通过促进细胞增殖和抑制细胞亡,在RB中发挥关键的致癌作用.
- 在RB中,MTHFD2的促进瘤效应通过Notch信号通路进行介导.
- 在视网膜母细胞瘤治疗中,MTHFD2 是一个有前途的治疗点.
相关概念视频
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Regulation of Angiogenesis and Blood Supply

